# CorneaGen LLC – FDA Inspection, Jan 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/corneagen-llc/a436e688-65c7-4558-a9dc-72388a0523f6
Source feed: FDA_Inspections

> FDA inspection 1195552 of CorneaGen LLC, January 13, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195552
- Company Name: CorneaGen LLC
- Inspection Date: 2023-01-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1320762 - 2026-04-30
- [FDA Inspection 1152947 - 2021-09-24](https://www.keypedia.com/records/fda_inspections/corneagen-llc/d1a660ae-7f2b-42ab-a32e-be6a9997c7f8)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)
- [Company Rep](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/corneagen-llc/d18bb473-fd82-468e-ad96-1d7f87189854

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
